Canine mammary tumors as a model for human disease (Review)
- Authors:
- Somaia M. Abdelmegeed
- Sulma Mohammed
-
Affiliations: Department of Comparative Pathobiology, Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA - Published online on: April 2, 2018 https://doi.org/10.3892/ol.2018.8411
- Pages: 8195-8205
-
Copyright: © Abdelmegeed et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Ghoncheh M, Pournamdar Z and Salehiniya H: Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 17:43–46. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO and Jemal A: International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 24:1495–1506. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
American Cancer Society: Cancer Facts & Figures. American Cancer Society, Inc.; Atlanta, GA: 2015 | |
|
Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, et al: Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer. 78:766–774. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Holen I, Speirs V, Morrissey B and Blyth K: In vivo models in breast cancer research: Progress, challenges and future directions. Dis Model Mech. 10:359–371. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Levenson AS and Jordan VC: MCF-7: The first hormone-responsive breast cancer cell line. Cancer Res. 57:3071–3078. 1997.PubMed/NCBI | |
|
Osborne CK, Hobbs K and Trent JM: Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 9:111–121. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Burdall SE, Hanby AM, Lansdown MR and Speirs V: Breast cancer cell lines: Friend or foe? Breast Cancer Res. 5:89–95. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Amadori D, Bertoni L, Flamigni A, Savini S, De Giovanni C, Casanova S, De Paola F, Amadori A, Giulotto E and Zoli W: Establishment and characterization of a new cell line from primary human breast carcinoma. Breast Cancer Res Treat. 28:251–260. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Yong JW, Choong ML, Wang S, Wang Y, Lim SQ and Lee MA: Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient. Cancer Cell Int. 14:942014. View Article : Google Scholar : PubMed/NCBI | |
|
Meltzer P, Leibovitz A, Dalton W, Villar H, Kute T, Davis J, Nagle R and Trent J: Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer. 63:727–735. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Cailleau R, Olivé M and Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In vitro. 14:911–915. 1978. View Article : Google Scholar : PubMed/NCBI | |
|
Engel LW and Young NA: Human breast carcinoma cells in continuous culture: A review. Cancer Res. 38:4327–4339. 1978.PubMed/NCBI | |
|
Nayak SK, Kakati S, Harvey SR, Malone CC, Cornforth AN and Dillman RO: Characterization of cancer cell lines established from two human metastatic breast cancers. In vitro Cell Dev Biol Anim. 36:188–193. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kurebayashi J, Otsuki T, Tang CK, Kurosumi M, Yamamoto S, Tanaka K, Mochizuki M, Nakamura H and Sonoo H: Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6. Br J Cancer. 79:707–717. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Rye PD, Norum L, Olsen DR, Garman-Vik S, Kaul S and Fodstad O: Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer. 68:682–687. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Zoli W, Roncuzzi L, Flamigni A, Gruppioni R, Sensi A, Zini N, Amadori D and Gasperi-Campani A: A new cell line from human infiltrating ductal carcinoma of the breast: Establishment and characterization. J Cancer Res Clin Oncol. 122:237–242. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ and Joyce MJ: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 38:3352–3364. 1978.PubMed/NCBI | |
|
Engebraaten O and Fodstad O: Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats. Int J Cancer. 82:219–225. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res Treat. 83:249–289. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Nelson-Rees WA, Daniels DW and Flandermeyer RR: Cross-contamination of cells in culture. Science. 212:446–452. 1981. View Article : Google Scholar : PubMed/NCBI | |
|
Rivenbark AG, O'Connor SM and Coleman WB: Molecular and cellular heterogeneity in breast cancer: Challenges for personalized medicine. Am J Pathol. 183:1113–1124. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Weiswald LB, Bellet D and Dangles-Marie V: Spherical cancer models in tumor biology. Neoplasia. 17:1–15. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ethier SP, Mahacek ML, Gullick WJ, Frank TS and Weber BL: Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 53:627–635. 1993.PubMed/NCBI | |
|
Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD and Gazdar AF: Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin Cancer Res. 4:2931–2938. 1998.PubMed/NCBI | |
|
Latimer JJ, Nazir T, Flowers LC, Forlenza MJ, Beaudry-Rodgers K, Kelly CM, Conte JA, Shestak K, Kanbour-Shakir A and Grant SG: Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures. Exp Cell Res. 291:111–121. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Freshney RI: Animal cell culture: a practical approach. IRL Press (Oxford University Press); Oxford: 1992 | |
|
Kim IS and Baek SH: Mouse models for breast cancer metastasis. Biochem Biophys Res Commun. 394:443–447. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Allred DC and Medina D: The relevance of mouse models to understanding the development and progression of human breast cancer. J Mammary Gland Biol Neoplasia. 13:279–288. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lewis MT and Porter WW: Methods in mammary gland biology and breast cancer research: An update. J Mammary Gland Biol Neoplasia. 14:3652009. View Article : Google Scholar : PubMed/NCBI | |
|
Perez C, Parker-Thornburg J, Mikulec C, Kusewitt DF, Fischer SM, Digiovanni J, Conti CJ and Benavides F: SKHIN/Sprd, a new genetically defined inbred hairless mouse strain for UV-induced skin carcinogenesis studies. Exp Dermatol. 21:217–220. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Borowsky A: Special considerations in mouse models of breast cancer. Breast Dis. 28:29–38. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Shen Q and Brown PH: Novel agents for the prevention of breast cancer: Targeting transcription factors and signal transduction pathways. J Mammary Gland Biol Neoplasia. 8:45–73. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Huijbers IJ, Krimpenfort P, Berns A and Jonkers J: Rapid validation of cancer genes in chimeras derived from established genetically engineered mouse models. Bioessays. 33:701–710. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ruggeri BA, Camp F and Miknyoczki S: Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochem Pharmacol. 87:150–161. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Du Z and Li Y: RCAS-TVA in the mammary gland: An in vivo oncogene screen and a high fidelity model for breast transformation? Cell Cycle. 6:823–826. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Balmain A and Harris CC: Carcinogenesis in mouse and human cells: Parallels and paradoxes. Carcinogenesis. 21:371–377. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Barrett JC: Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect. 100:9–20. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, et al: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program. J Cell Biochem Suppl. 20:32–54. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Abel EL, Angel JM, Kiguchi K and DiGiovanni J: Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications. Nat Protoc. 4:1350–1362. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tsukamoto T, Mizoshita T and Tatematsu M: Animal models of stomach carcinogenesis. Toxicol Pathol. 35:636–648. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Takahashi M, Hori M, Mutoh M, Wakabayashi K and Nakagama H: Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease. Cancers (Basel). 3:582–602. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell. 140:883–899. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Shoushtari AN, Michalowska AM and Green JE: Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast Dis. 28:39–51. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Pichon MF, Broet P, Magdelenat H, Delarue JC, Spyratos F, Basuyau JP, Saez S, Rallet A, Courriere P, Millon R and Asselain B: Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer. 73:1545–1551. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Schernhammer ES, Holly JM, Hunter DJ, Pollak MN and Hankinson SE: Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in the nurses health study II. Endocr Relat Cancer. 13:583–592. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kleinberg DL, Wood TL, Furth PA and Lee AV: Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev. 30:51–74. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Selman PJ, Mol JA, Rutteman GR, van Garderen E and Rijnberk A: Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology. 134:287–292. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Mehta RR, Graves JM, Hart GD, Shilkaitis A and Das Gupta TK: Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res Treat. 25:65–71. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Gandhi A, Holland PA, Knox WF, Potten CS and Bundred NJ: Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ. Cancer Res. 60:4284–4288. 2000.PubMed/NCBI | |
|
Chan KC, Knox WF, Gee JM, Morris J, Nicholson RI, Potten CS and Bundred NJ: Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast. Cancer Res. 62:122–128. 2002.PubMed/NCBI | |
|
Shanks N, Greek R and Greek J: Are animal models predictive for humans? Philos Ethics Humanit Med. 4:22009. View Article : Google Scholar : PubMed/NCBI | |
|
Ericsson AC, Crim MJ and Franklin CL: A brief history of animal modeling. Mo Med. 110:201–205. 2013.PubMed/NCBI | |
|
Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest. 62:244–278. 1990.PubMed/NCBI | |
|
Russo J and Russo IH: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia. 5:187–200. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Szpirer C: Cancer research in rat models. Methods Mol Biol. 597:445–458. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Russo IH and Russo J: Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst. 61:1439–1449. 1978.PubMed/NCBI | |
|
Thompson HJ, Adlakha H and Singh M: Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis. 13:1535–1539. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Thompson HJ and Meeker LD: Induction of mammary gland carcinomas by the subcutaneous injection of 1-methyl-1-nitrosourea. Cancer Res. 43:1628–1629. 1983.PubMed/NCBI | |
|
Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas J and Russo IH: Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev. 15:306–342. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Nandi S, Guzman RC and Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc Natl Acad Sci USA. 92:3650–3657. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Holliday R: Neoplastic transformation: The contrasting stability of human and mouse cells. Cancer Surv. 28:103–115. 1996.PubMed/NCBI | |
|
Holt MP, Shevach EM and Punkosdy GA: Endogenous mouse mammary tumor viruses (mtv): New roles for an old virus in cancer, infection and immunity. Front Oncol. 3:2872013. View Article : Google Scholar : PubMed/NCBI | |
|
Wong M, Pagano JS, Schiller JT, Tevethia SS, Raab-Traub N and Gruber J: New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst. 94:1832–1836. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Newbold RF: Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found Symp. 211:177–197. 1997.PubMed/NCBI | |
|
Greenberg RA, Allsopp RC, Chin L, Morin GB and DePinho RA: Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene. 16:1723–1730. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Cabuy E, Newton C, Roberts T, Newbold R and Slijepcevic P: Identification of subpopulations of cells with differing telomere lengths in mouse and human cell lines by flow FISH. Cytometry A. 62:150–161. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, et al: The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting. Oncogene. 19:968–988. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Cardiff RD: Validity of mouse mammary tumour models for human breast cancer: Comparative pathology. Microsc Res Tech. 52:224–230. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Savage VM, Allen AP, Brown JH, Gillooly JF, Herman AB, Woodruff WH and West GB: Scaling of number, size, and metabolic rate of cells with body size in mammals. Proc Natl Acad Sci USA. 104:4718–4723. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Helczynska K, Kronblad A, Jögi A, Nilsson E, Beckman S, Landberg G and Påhlman S: Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 63:1441–1444. 2003.PubMed/NCBI | |
|
Walrath JC, Hawes JJ, Van Dyke T and Reilly KM: Genetically engineered mouse models in cancer research. Adv Cancer Res. 106:113–164. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gomez-Cuadrado L, Tracey N, Ma R, Qian B and Brunton VG: Mouse models of metastasis: Progress and prospects. Dis Model Mech. 10:1061–1074. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Frese KK and Tuveson DA: Maximizing mouse cancer models. Nat Rev Cancer. 7:645–658. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rahman M and Mohammed S: Breast cancer metastasis and the lymphatic system. Oncol Lett. 10:1233–1239. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kucherlapati R: Genetically modified mouse models for biomarker discovery and preclinical drug testing. Clin Cancer Res. 18:625–630. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Olive KP and Tuveson DA: The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Clin Cancer Res. 12:5277–5287. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Huang G, Ashton C, Kumbhani DS and Ying QL: Genetic manipulations in the rat: Progress and prospects. Curr Opin Nephrol Hypertens. 20:391–399. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cheung A, Young L, Chen P, Chao C, Ndoye A, Barry P, Muller W and Cardiff R: Microcirculation and metastasis in a new mouse mammary tumor model system. Int J Oncol. 11:69–77. 1997.PubMed/NCBI | |
|
Wiese DA, Thaiwong T, Yuzbasiyan-Gurkan V and Kiupel M: Feline mammary basal-like adenocarcinomas: A potential model for human triple-negative breast cancer (TNBC) with basal-like subtype. BMC Cancer. 13:4032013. View Article : Google Scholar : PubMed/NCBI | |
|
De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B and Di Renzo MF: Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res. 65:907–912. 2005.PubMed/NCBI | |
|
Burrai GP, Mohammed SI, Miller MA, Marras V, Pirino S, Addis MF, Uzzau S and Antuofermo E: Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions. BMC Cancer. 10:1562010. View Article : Google Scholar : PubMed/NCBI | |
|
Weijer K, Head KW, Misdorp W and Hampe JF: Feline malignant mammary tumors. I. Morphology and biology: Some comparisons with human and canine mammary carcinomas. J Natl Cancer Inst. 49:1697–1704. 1972. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Xiao C, Vonderhaar BK and Deng CX: A role of estrogen/ERalpha signaling in BRCA1-associated tissue-specific tumor formation. Oncogene. 26:7204–7212. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lin SC, Lee KF, Nikitin AY, Hilsenbeck SG, Cardiff RD, Li A, Kang KW, Frank SA, Lee WH and Lee EY: Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res. 64:3525–3532. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Jang JW, Boxer RB and Chodosh LA: Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis. Mol Cell Biol. 26:8109–8121. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Owen LN: A comparative study of canine and human breast cancer. Invest Cell Pathol. 2:257–275. 1979.PubMed/NCBI | |
|
Queiroga FL, Raposo T, Carvalho MI, Prada J and Pires I: Canine mammary tumours as a model to study human breast cancer: Most recent findings. In vivo. 25:455–465. 2011.PubMed/NCBI | |
|
Glass AG, Lacey JV Jr, Carreon JD and Hoover RN: Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 99:1152–1161. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Pollan M, Pastor-Barriuso R, Ardanaz E, Argüelles M, Martos C, Galcerán J, Sánchez-Pérez MJ, Chirlaque MD, Larrañaga N, Martínez-Cobo R, et al: Recent changes in breast cancer incidence in Spain, 1980–2004. J Natl Cancer Inst. 101:1584–1591. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Dobson JM, Samuel S, Milstein H, Rogers K and Wood JL: Canine neoplasia in the UK: Estimates of incidence rates from a population of insured dogs. J Small Anim Pract. 43:240–246. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Misdorp W: Armed Forces Institute of Pathology (U.S.); American Registry of Pathology.; WHO Collaborating Center for Worldwide Reference on Comparative Oncology: Histological classification of mammary tumors of the dog and the cat. Washington: Armed Forces Institute of Pathology in cooperation with the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology. Comp Oncol. 7:591999. | |
|
Antuofermo E, Miller MA, Pirino S, Xie J, Badve S and Mohammed SI: Spontaneous mammary intraepithelial lesions in dogs-a model of breast cancer. Cancer Epidemiol Biomarkers Prev. 16:2247–2256. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Schneider R: Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer. 26:419–426. 1970. View Article : Google Scholar : PubMed/NCBI | |
|
Rutteman GR, Misdorp W, Blankenstein MA and van den Brom WE: Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states. Br J Cancer. 58:594–599. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Fisher ER, Sass R and Fisher B: Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors. Cancer. 59:1554–1559. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Lamote I, Meyer E, Massart-Leen AM and Burvenich C: Sex steroids and growth factors in the regulation of mammary gland proliferation, differentiation, and involution. Steroids. 69:145–159. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Elston CW: Classification and grading of invasive breast carcinoma. Verh Dtsch Ges Pathol. 89:35–44. 2005.PubMed/NCBI | |
|
de las Mulas Martín J, Ordás J, Millán MY, Chacón F, De Lara M, de los Monteros Espinosa A, Reymundo C and Jover A: Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands. Vet Pathol. 41:269–272. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Edén P, Peterson C, Malmström P, Isola J, Borg A and Fernö M: Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Clin Cancer Res. 13:1987–1994. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Saji S, Hirose M and Toi M: Clinical significance of estrogen receptor beta in breast cancer. Cancer Chemother Pharmacol. 56 Suppl 1:S21–S26. 2005. View Article : Google Scholar | |
|
Joensuu K, Leidenius M, Kero M, Andersson LC, Horwitz KB and Heikkilä P: ER, PR, HER2, Ki-67 and CK5 in early and late relapsing breast cancer-reduced CK5 expression in metastases. Breast Cancer (Auckl). 7:23–34. 2013.PubMed/NCBI | |
|
Gelbfish GA, Davidson AL, Kopel S, Schreibman B, Gelbfish JS, Degenshein GA, Herz BL and Cunningham JN: Relationship of estrogen and progesterone receptors to prognosis in breast cancer. Ann Surg. 207:75–79. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Mouttet D, Laé M, Caly M, Gentien D, Carpentier S, Peyro-Saint-Paul H, Vincent-Salomon A, Rouzier R, Sigal-Zafrani B, Sastre-Garau X and Reyal F: Estrogen-receptor, progesterone-receptor and HER2 status determination in invasive breast cancer. Concordance between immuno-histochemistry and MapQuant™ microarray based assay. PLoS One. 11:e01464742016. View Article : Google Scholar : PubMed/NCBI | |
|
Krajcik RA, Borofsky ND, Massardo S and Orentreich N: Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev. 11:1566–1573. 2002.PubMed/NCBI | |
|
van Garderen E, de Wit M, Voorhout WF, Rutteman GR, Mol JA, Nederbragt H and Misdorp W: Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop. Am J Pathol. 150:1037–1047. 1997.PubMed/NCBI | |
|
van Garderen E, van der Poel HJ, Swennenhuis JF, Wissink EH, Rutteman GR, Hellmén E, Mol JA and Schalken JA: Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors. Endocrinology. 140:5907–5914. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Divisova J, Kuiatse I, Lazard Z, Weiss H, Vreeland F, Hadsell DL, Schiff R, Osborne CK and Lee AV: The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Res Treat. 98:315–327. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Queiroga FL, Pérez-Alenza MD, Silvan G, Peña L, Lopes CS and Illera JC: Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours. J Steroid Biochem Mol Biol. 110:76–82. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Queiroga FL, Pérez-Alenza D, Silvan G, Peña L, Lopes CS and Illera JC: Serum and intratumoural GH and IGF-I concentrations: Prognostic factors in the outcome of canine mammary cancer. Res Vet Sci. 89:396–403. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yin D, Vreeland F, Schaaf LJ, Millham R, Duncan BA and Sharma A: Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: Implications for cancer therapy. Clin Cancer Res. 13:1000–1009. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hobbs JR and Salih H: Prolactin dependence in human breast cancer. Proc R Soc Med. 66:8661973.PubMed/NCBI | |
|
Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, Nicholson RI and Sutherland RL: Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab. 82:3692–3699. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Queiroga FL, Pérez-Alenza MD, Silvan G, Peña L, Lopes C and Illera JC: Role of steroid hormones and prolactin in canine mammary cancer. J Steroid Biochem Mol Biol. 94:181–187. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Visan S, Balacescu O, Berindan-Neagoe I and Catoi C: In vitro comparative models for canine and human breast cancers. Clujul Med. 89:38–49. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, Castle J, Palombo F, Viti V, Mesiti G, Zappulli V, et al: Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics. 10:1352009. View Article : Google Scholar : PubMed/NCBI | |
|
Egenvall A, Bonnett BN, Ohagen P, Olson P, Hedhammar A and von Euler H: Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med. 69:109–127. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Rivera P, Melin M, Biagi T, Fall T, Häggström J, Lindblad-Toh K and von Euler H: Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Cancer Res. 69:8770–8774. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ochiai K, Morimatsu M, Tomizawa N and Syuto B: Cloning and sequencing full length of canine Brca2 and Rad51 cDNA. J Vet Med Sci. 63:1103–1108. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Nieto A, Pérez-Alenza MD, Del Castillo N, Tabanera E, Castaño M and Peña L: BRCA1 expression in canine mammary dysplasias and tumours: Relationship with prognostic variables. J Comp Pathol. 128:260–268. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Klopfleisch R and Gruber AD: Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas. Vet Pathol. 46:416–422. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Rajan JV, Marquis ST, Gardner HP and Chodosh LA: Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol. 184:385–401. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF and Ellis IO: Prognostic markers in triple-negative breast cancer. Cancer. 109:25–32. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gama A, Gärtner F, Alves A and Schmitt F: Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. Res Vet Sci. 87:432–437. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Queiroga FL, Perez-Alenza D, Silvan G, Peña L and Illera JC: Positive correlation of steroid hormones and EGF in canine mammary cancer. J Steroid Biochem Mol Biol. 115:9–13. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L and Bloom KJ: The Her-2/neu gene and protein in breast cancer 2003: Biomarker and target of therapy. Oncologist. 8:307–325. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Rungsipipat A, Tateyama S, Yamaguchi R, Uchida K, Miyoshi N and Hayashi T: Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. J Vet Med Sci. 61:27–32. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Kerns BJ, Pence JC, Huper G, Kinney RB and Iglehart JD: c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry. J Histochem Cytochem. 38:1823–1830. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Paredes J, Lopes N, Milanezi F and Schmitt FC: P-cadherin and cytokeratin 5: Useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Arch. 450:73–80. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI and Ellis IO: Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 203:661–671. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gama A, Alves A and Schmitt F: Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: Application of the human classification. Virchows Arch. 453:123–132. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 133:1710–1715. 1984.PubMed/NCBI | |
|
Peña LL, Nieto AI, Pérez-Alenza D, Cuesta P and Castaño M: Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: Relationship to clinical and pathologic variables. J Vet Diagn Invest. 10:237–246. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Railo M, Nordling S, von Boguslawsky K, Leivonen M, Kyllönen L and von Smitten K: Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer. 68:579–583. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Thomas M, Noguchi M, Kitagawa H, Kinoshita K and Miyazaki I: Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma. J Clin Pathol. 46:525–528. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N and Doi K: Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol. 37:177–183. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kumaraguruparan R, Prathiba D and Nagini S: Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours. Res Vet Sci. 81:218–224. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Velculescu VE and El-Deiry WS: Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem. 42:858–868. 1996.PubMed/NCBI | |
|
Beenken SW, Grizzle WE, Crowe DR, Conner MG, Weiss HL, Sellers MT, Krontiras H, Urist MM and Bland KI: Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53. Ann Surg. 233:630–638. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Lee CH and Kweon OK: Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors. J Vet Sci. 3:321–325. 2002.PubMed/NCBI | |
|
Chu LL, Rutteman GR, Kong JM, Ghahremani M, Schmeing M, Misdorp W, van Garderen E and Pelletier J: Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia. Breast Cancer Res Treat. 50:11–25. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Veldhoen N, Watterson J, Brash M and Milner J: Identification of tumour-associated and germ line p53 mutations in canine mammary cancer. Br J Cancer. 81:409–415. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Muto T, Wakui S, Takahashi H, Maekawa S, Masaoka T, Ushigome S and Furusato M: p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog. Vet Pathol. 37:248–253. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Moll UM and Slade N: p63 and p73: Roles in development and tumor formation. Mol Cancer Res. 2:371–386. 2004.PubMed/NCBI | |
|
McKeon FD: p63 and p73 in tumor suppression and promotion. Cancer Res Treat. 36:6–12. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Matos I, Dufloth R, Alvarenga M, Zeferino LC and Schmitt F: p63, cytokeratin 5, and P-cadherin: Three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 447:688–694. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Stefanou D, Batistatou A, Nonni A, Arkoumani E and Agnantis NJ: p63 expression in benign and malignant breast lesions. Histol Histopathol. 19:465–471. 2004.PubMed/NCBI | |
|
Desantis CRS and Jemal A: Breast cancer facts & figures 2015–2016. Am Cancer Soc. 44:2015. | |
|
Gama A, Alves A, Gartner F and Schmitt F: p63: A novel myoepithelial cell marker in canine mammary tissues. Vet Pathol. 40:412–420. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Elmore JG, Armstrong K, Lehman CD and Fletcher SW: Screening for breast cancer. JAMA. 293:1245–1256. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Morgan MP, Cooke MM and McCarthy GM: Microcalcifications associated with breast cancer: An epiphenomenon or biologically significant feature of selected tumors? J Mammary Gland Biol Neoplasia. 10:181–187. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Muttarak M, Kongmebhol P and Sukhamwang N: Breast calcifications: Which are malignant? Singapore Med J. 50:907–914. 2009.PubMed/NCBI | |
|
Burnside ES, Sickles EA, Bassett LW, Rubin DL, Lee CH, Ikeda DM, Mendelson EB, Wilcox PA, Butler PF and D'Orsi CJ: The ACR BI-RADS experience: Learning from history. J Am Coll Radiol. 6:851–860. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ernster VL and Barclay J: Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: A dilemma. J Natl Cancer Inst Monogr. 151–156. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Mohammed SI, Meloni GB, Parpaglia Pinna ML, Marras V, Burrai GP, Meloni F, Pirino S and Antuofermo E: Mammography and ultrasound imaging of preinvasive and invasive canine spontaneous mammary cancer and their similarities to human breast cancer. Cancer Prev Res (Phila). 4:1790–1798. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cekanova M and Rathore K: Animal models and therapeutic molecular targets of cancer: Utility and limitations. Drug Des Devel Ther. 8:1911–1921. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Decker WK, da Silva RF, Sanabria MH, Angelo LS, Guimarães F, Burt BM, Kheradmand F and Paust S: Cancer immunotherapy: Historical perspective of a clinical revolution and emerging preclinical animal models. Front Immunol. 8:8292017. View Article : Google Scholar : PubMed/NCBI | |
|
Estrela-Lima A, Araújo MS, Costa-Neto JM, Teixeira-Carvalho A, Barrouin-Melo SM, Cardoso SV, Martins-Filho OA, Serakides R and Cassali GD: Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer. 10:2562010. View Article : Google Scholar : PubMed/NCBI | |
|
Akiyama F and Horii R: Therapeutic strategies for breast cancer based on histological type. Breast Cancer. 16:168–172. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sorenmo KU, Kristiansen VM, Cofone MA, Shofer FS, Breen AM, Langeland M, Mongil CM, Grondahl AM, Teige J and Goldschmidt MH: Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol. 7:162–172. 2009. View Article : Google Scholar : PubMed/NCBI |
